• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Death Differ . SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination

tetano

Editor, Senior Moderator
Cell Death Differ


. 2021 Apr 20.
doi: 10.1038/s41418-021-00782-3. Online ahead of print.
SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination


Zhengrong Zhang[SUP] #[/SUP][SUP] 1 2 [/SUP], You Zheng[SUP] #[/SUP][SUP] 1 [/SUP], Zubiao Niu[SUP] #[/SUP][SUP] 1 [/SUP], Bo Zhang[SUP] #[/SUP][SUP] 1 2 [/SUP], Chenxi Wang[SUP] #[/SUP][SUP] 1 [/SUP], Xiaohong Yao[SUP] #[/SUP][SUP] 3 [/SUP], Haoran Peng[SUP] 4 [/SUP], Del Nonno Franca[SUP] 5 [/SUP], Yunyun Wang[SUP] 6 [/SUP], Yichao Zhu[SUP] 1 [/SUP], Yan Su[SUP] 1 [/SUP], Meng Tang[SUP] 1 2 [/SUP], Xiaoyi Jiang[SUP] 1 2 [/SUP], He Ren[SUP] 1 2 [/SUP], Meifang He[SUP] 7 [/SUP], Yuqi Wang[SUP] 1 [/SUP], Lihua Gao[SUP] 1 [/SUP], Ping Zhao[SUP] 4 [/SUP], Hanping Shi[SUP] 2 [/SUP], Zhaolie Chen[SUP] 1 [/SUP], Xiaoning Wang[SUP] 8 9 [/SUP], Mauro Piacentini[SUP] 5 10 [/SUP], Xiuwu Bian[SUP] 3 [/SUP], Gerry Melino[SUP] 11 12 [/SUP], Liang Liu[SUP] 13 [/SUP], Hongyan Huang[SUP] 14 [/SUP], Qiang Sun[SUP] 15 16 [/SUP]



Affiliations

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is highly contagious and causes lymphocytopenia, but the underlying mechanisms are poorly understood. We demonstrate here that heterotypic cell-in-cell structures with lymphocytes inside multinucleate syncytia are prevalent in the lung tissues of coronavirus disease 2019 (COVID-19) patients. These unique cellular structures are a direct result of SARS-CoV-2 infection, as the expression of the SARS-CoV-2 spike glycoprotein is sufficient to induce a rapid (~45.1 nm/s) membrane fusion to produce syncytium, which could readily internalize multiple lines of lymphocytes to form typical cell-in-cell structures, remarkably leading to the death of internalized cells. This membrane fusion is dictated by a bi-arginine motif within the polybasic S1/S2 cleavage site, which is frequently present in the surface glycoprotein of most highly contagious viruses. Moreover, candidate anti-viral drugs could efficiently inhibit spike glycoprotein processing, membrane fusion, and cell-in-cell formation. Together, we delineate a molecular and cellular rationale for SARS-CoV-2 pathogenesis and identify novel targets for COVID-19 therapy.
 
Back
Top Bottom